Protein kinase WNK2 inhibits cell proliferation by negatively modulating the activation of MEK1/ERK1/2 (original) (raw)

• Alessi DR, Saito Y, Campbell DG, Cohen P, Sithanandam G, Rapp U et al. (1994). Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1. EMBO J 13: 1610–1619.
  Article CAS PubMed PubMed Central Google Scholar
• Balmanno K, Cook SJ . (1999). Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells. Oncogene 18: 3085–3097.
  Article CAS PubMed Google Scholar
• Coles LC, Shaw PE . (2002). PAK1 primes MEK1 for phosphorylation by Raf-1 kinase during cross-cascade activation of the ERK pathway. Oncogene 21: 2236–2244.
  Article CAS PubMed Google Scholar
• Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S et al. (2002). Mutations in the BRAF gene in human cancer. Nature 417: 949–954.
  Article CAS PubMed Google Scholar
• Dobrowolski S, Harter M, Stacey DW . (1994). Cellular ras activity is required for passage through multiple points of the G0/G1 phase in BALB/c 3T3 cells. Mol Cell Biol 14: 5441–5449.
  Article CAS PubMed PubMed Central Google Scholar
• Ebisuya M, Kondoh K, Nishida E . (2005). The duration, magnitude and compartmentalization of ERK MAP kinase activity: mechanisms for providing signaling specificity. J Cell Sci 118: 2997–3002.
  Article CAS PubMed Google Scholar
• Eblen ST, Slack JK, Weber MJ, Catling AD . (2002). Rac-PAK signaling stimulates extracellular signal-regulated kinase (ERK) activation by regulating formation of MEK1-ERK complexes. Mol Cell Biol 22: 6023–6033.
  Article CAS PubMed PubMed Central Google Scholar
• Frost JA, Steen H, Shapiro P, Lewis T, Ahn N, Shaw PE et al. (1997). Cross-cascade activation of ERKs and ternary complex factors by Rho family proteins. EMBO J 16: 6426–6438.
  Article CAS PubMed PubMed Central Google Scholar
• Gagnon KB, England R, Delpire E . (2006). Characterization of SPAK and OSR1, regulatory kinases of the Na-K-2Cl cotransporter. Mol Cell Biol 26: 689–698.
  Article CAS PubMed PubMed Central Google Scholar
• Gamba G . (2005). Role of WNK kinases in regulating tubular salt and potassium transport and in the development of hypertension. Am J Physiol Renal Physiol 288: F245–F252.
  Article CAS PubMed Google Scholar
• Gschwind A, Fischer OM, Ullrich A . (2004). The discovery of receptor tyrosine kinases: targets for cancer therapy. Nat Rev Cancer 4: 361–370.
  Article CAS PubMed Google Scholar
• Hanks SK, Hunter T . (1995). The eucaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J 9: 576–596.
  Article CAS PubMed Google Scholar
• Hong C, Moorefield KS, Jun P, Aldape KD, Kharbanda S, Phillips HS et al. (2007). Epigenome scans and cancer genome sequencing converge on WNK2, a kinase-independent suppressor of cell growth. Proc Natl Acad Sci USA 104: 10974–10979.
  Article CAS PubMed PubMed Central Google Scholar
• Ito M, Shichijo S, Tsuda N, Ochi M, Harashima N, Saito N et al. (2001). Molecular basis of T cell-mediated recognition of pancreatic cancer cells. Cancer Res 61: 2038–2046.
  CAS PubMed Google Scholar
• Jiang ZY, Zhou QL, Holik J, Patel S, Leszyk J, Coleman K et al. (2005). Identification of WNK1 as a substrate of Akt/protein kinase B and a negative regulator of insulin-stimulated mitogenesis in 3T3-L1 cells. J Biol Chem 280: 21622–21628.
  Article CAS PubMed Google Scholar
• Kahle KT, Wilson FH, Lalioti M, Toka H, Qin H, Lifton RP . (2004). WNK kinases: molecular regulators of integrated epithelial ion transport. Curr Opin Nephrol Hypertens 13: 557–562.
  Article CAS PubMed Google Scholar
• Kerkhoff E, Rapp UR . (1998). High-intensity Raf signals convert mitotic cell cycling into cellular growth. Cancer Res 58: 1636–1640.
  CAS PubMed Google Scholar
• Kostich M, English J, Madison V, Gheyas F, Wang L, Qiu P et al. (2002). Human members of the eukaryotic protein kinase family. Genome Biol 3: RESEARCH0043.
  Article Google Scholar
• Lee BH, Min X, Heise CJ, Xu BE, Chen S, Shu H et al. (2004). WNK1 phosphorylates synaptotagmin 2 and modulates its membrane binding. Mol Cell 15: 741–751.
  Article CAS PubMed Google Scholar
• Lenertz LY, Lee BH, Min X, Xu BE, Wedin K, Earnest S et al. (2005). Properties of WNK1 and implications for other family members. J Biol Chem 280: 26653–26658.
  Article CAS PubMed Google Scholar
• Li W, Han M, Guan KL . (2000). The leucine-rich repeat protein SUR-8 enhances MAP kinase activation and forms a complex with Ras and Raf. Genes Dev 14: 895–900.
  CAS PubMed PubMed Central Google Scholar
• Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S . (2002). The protein kinase complement of the human genome. Science 298: 1912–1934.
  Article CAS PubMed Google Scholar
• Marshall CJ . (1995). Specificity of receptor tyrosine kinase signalling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80: 179–185.
  Article CAS PubMed Google Scholar
• Matheny SA, Chen C, Kortum RL, Razidlo GL, Lewis RE, White MA . (2004). Ras regulates assembly of mitogenic signalling complexes through the effector protein IMP. Nature 427: 256–260.
  Article CAS PubMed Google Scholar
• Matos P, Jordan P . (2005). Expression of Rac1b stimulates NF-_κ_B-mediated cell survival and G1/S-progression. Exp Cell Res 305: 292–299.
  Article CAS PubMed Google Scholar
• Min X, Lee BH, Cobb MH, Goldsmith EJ . (2004). Crystal structure of the kinase domain of WNK1, a kinase that causes a hereditary form of hypertension. Structure 12: 1303–1311.
  Article CAS PubMed Google Scholar
• Moriguchi T, Urushiyama S, Hisamoto N, Iemura S, Uchida S, Natsume T et al. (2005). WNK1 regulates phosphorylation of cation-chloride-coupled cotransporters via the STE20-related kinases, SPAK and OSR1. J Biol Chem 280: 42685–42693.
  Article CAS PubMed Google Scholar
• Morrison DK, Davis RJ . (2003). Regulation of MAP kinase signalling modules by scaffold proteins in mammals. Annu Rev Cell Dev Biol 19: 91–118.
  Article CAS PubMed Google Scholar
• Murphy LO, MacKeigan JP, Blenis J . (2004). A network of immediate early gene products propagates subtle differences in mitogen-activated protein kinase signal amplitude and duration. Mol Cell Biol 24: 144–153.
  Article CAS PubMed PubMed Central Google Scholar
• Park ER, Eblen ST, Catling AD . (2007). MEK1 activation by PAK: a novel mechanism. Cell Signal 19: 1488–1496.
  Article CAS PubMed PubMed Central Google Scholar
• Rodriguez-Viciana P, Tetsu O, Oda K, Okada J, Rauen K, McCormick F . (2005). Cancer targets in the Ras pathway. Cold Spring Harb Symp Quant Biol 70: 461–467.
  Article CAS PubMed Google Scholar
• Scanlan MJ, Chen YT, Williamson B, Gure AO, Stockert E, Gordan JD et al. (1998). Characterization of human colon cancer antigens recognized by autologous antibodies. Int J Cancer 76: 652–658.
  Article CAS PubMed Google Scholar
• Sebolt-Leopold JS, Herrera R . (2004). Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat Rev Cancer 4: 937–947.
  Article CAS PubMed Google Scholar
• Sewing A, Wiseman B, Lloyd AC, Land H . (1997). High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1. Mol Cell Biol 17: 5588–5597.
  Article CAS PubMed PubMed Central Google Scholar
• Slack-Davis JK, Eblen ST, Zecevic M, Boerner SA, Tarcsafalvi A, Diaz HB et al. (2003). PAK1 phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activation. J Cell Biol 162: 281–291.
  Article CAS PubMed PubMed Central Google Scholar
• Veríssimo F, Jordan P . (2001). WNK kinases, a novel protein kinase subfamily in multi-cellular organisms. Oncogene 20: 5562–5569.
  Article PubMed Google Scholar
• Veríssimo F, Silva E, Morris JD, Pepperkok R, Jordan P . (2006). Protein kinase WNK3 increases cell survival in a caspase 3-dependent pathway. Oncogene 25: 4172–4182.
  Article PubMed Google Scholar
• Vitari AC, Deak M, Collins BJ, Morrice N, Prescott AR, Phelan A et al. (2004). WNK1, the kinase mutated in an inherited high-blood-pressure syndrome, is a novel PKB (protein kinase B)/Akt substrate. Biochem J 378: 257–268.
  Article CAS PubMed PubMed Central Google Scholar
• Vitari AC, Deak M, Morrice NA, Alessi DR . (2005). The WNK1 and WNK4 protein kinases that are mutated in Gordon's hypertension syndrome phosphorylate and activate SPAK and OSR1 protein kinases. Biochem J 391: 17–24.
  Article CAS PubMed PubMed Central Google Scholar
• Wellbrock C, Karasarides M, Marais R . (2004). The RAF proteins take centre stage. Nat Rev Mol Cell Biol 5: 875–885.
  Article CAS PubMed Google Scholar
• Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Desitter I et al. (2001). Human hypertension caused by mutations in WNK kinases. Science 293: 1107–1112.
  Article CAS PubMed Google Scholar
• Woods D, Parry D, Cherwinski H, Bosch E, Lees E, McMahon M . (1997). Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1. Mol Cell Biol 17: 5598–5611.
  Article CAS PubMed PubMed Central Google Scholar
• Xu BE, English JM, Wilsbacher JL, Stippec S, Goldsmith EJ, Cobb MH . (2000). WNK1, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II. J Biol Chem 275: 16795–16801.
  Article CAS PubMed Google Scholar
• Xu BE, Stippec S, Chu PY, Lazrak A, Li XJ, Lee BH et al. (2005). WNK1 activates SGK1 to regulate the epithelial sodium channel. Proc Natl Acad Sci USA 102: 10315–10320.
  Article CAS PubMed PubMed Central Google Scholar
• Xu BE, Stippec S, Lenertz L, Lee B-H, Zhang W, Lee YK et al. (2004). WNK1 activates ERK5 by an MEKK2/3-dependent mechanism. J Biol Chem 279: 7826–7831.
  Article CAS PubMed Google Scholar
• Zheng CF, Guan KL . (1994). Activation of MEK family kinases requires phosphorylation of two conserved Ser/Thr residues. EMBO J 13: 1123–1131.
  Article CAS PubMed PubMed Central Google Scholar